Anxiety, Behavioral Health Concerns, Critical Care, Intensive Care, Critical Illness Recovery, Depression - Major Depressive Disorder, PICS-F, PTSD
Conditions
Keywords
Critical Ilness, critical care recovery, Post-Intensive Care Syndrome, Post-ICU care, behavioral health, mental health, anxiety, depression, PTSD, PICS-F
Brief summary
This pilot study evaluates the feasibility and acceptability of implementing a Behavioral Health Collaborative Care Model (BH CoCM) for family members of ICU survivors. The intervention includes telehealth-enabled behavioral health assessments and access to the NeuroFlow platform. A subset of participants will undergo qualitative interviews.
Detailed description
Patients seen in the MUSC ICU Recovery Clinic will be approached for consent for care through our Behavioral Health Collaborative Care Model. Patients and their families that consent will be randomized to an attention control group or an intervention group. The intervention group will have access to NeuroFlow platform, which has been specifically designed to support delivery of a BH CoCM. They will utilize Neuroflow for 6 months. They will undergo assessments for anxiety, depression, post-traumatic stress The attention control group will undergo assessments for anxiety, depression, post-traumatic stress. Investigators will look at changes over six months in intervention group compared to attention control group for patients in terms of symptoms of depression, anxiety, post-traumatic stress. Investigators will also look at adherence, BH CoCM implementation metrics, type and amount of guided content accessed in NeuroFlow. Investigators will perform qualitative surveys to understand better what patients thought about the intervention and ways in which it could be improved.
Interventions
behavioral health collaborative care model in ICU recovery patients and families
Sponsors
Study design
Eligibility
Inclusion criteria
\- Family member of ICU Recovery Clinic patient enrolled in parent BH CoCM study
Exclusion criteria
* Serious mental illness (e.g., schizophrenia, mania) * Late-stage dementia or cognitive impairment * Limited English proficiency * No internet-enabled device * Prisoners
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Consent Rate | Baseline | Investigators will assess the consent rate |
| Study Completion Rate | enrollment to 6 months | We will assess the completion rate of all enrolled family members |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Monthly Completion Rate of PHQ9 (Patient Health Questionnaire 9) | Enrollment to 6 months | Rate of completion of scheduled monthly assessment: PHQ9 |
| Monthly Completion Rate of GAD 7 (General Anxiety Disorder 7) | baseline to 6 months | Rate of completion of scheduled monthly assessment: GAD7 |
| Monthly Completion Rate of PCL 5 (PTSD Checklist for DSM-5) | baseline to 6 months | Rate of Completion of scheduled monthly assessment: PCL5 |
Countries
United States
Contacts
Medical University of South Carolina